-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

801.O1.6 801. Gene Therapies: Gene Editing and Replacement Therapies for Hemoglobinopathies: From Bench to Bedside

Symposia: Gene Therapies Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Clinical trials, Fundamental Science, Sickle Cell Disease, Adult, Translational Research, Sickle Cell Trait, Clinical Research, Thalassemia, Genetic Disorders, Hemoglobinopathies, Pediatric, Diseases, Gene Therapy, Treatment Considerations, Biological therapies, Emerging technologies, Gene editing, Technology and Procedures, Study Population, Human
Sunday, December 8, 2024: 9:30 AM-11:00 AM
Room 30 (San Diego Convention Center)
Moderators:
Harinad Maganti, PhD, and Ashish O. Gupta, MBBS, MPH,
Disclosures:
No relevant conflicts of interest to declare.
9:30 AM

Stacey Rifkin-Zenenberg, DO1, Julie Kanter, MD2, Melissa A. Kinney3*, Janet L. Kwiatkowski, MD4,5, Robert S. Nickel, MD, MSc6, Mark C. Walters, MD7*, Suhag Parikh, MD8*, Alexis Thompson, MD, MPH5,9, Anil P. George10*, Markus Mapara, MD, PhD11*, Paul L. Martin, MD, PhD12, Anjulika Chawla, MD, FAAP3, Ankit Lodaya, MS3*, Lin Pan3*, Emily Sheldon-Waniga, PhD3*, Francis J. Pierciey Jr., MSc3*, John Tisdale, MD13 and Ashish O. Gupta, MBBS, MPH14

1Pediatric Hematology/Oncology Division, Hackensack University Medical Center, Hackensack, NJ
2University of Alabama at Birmingham, Birmingham, AL
3bluebird bio, Inc., Somerville, MA
4Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
5Children's Hospital of Philadelphia, Philadelphia, PA
6Children's National Hospital, Washington, DC
7University of California, San Francisco Benioff Children’s Hospital, Oakland, CA
8Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University, Atlanta, GA
9Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
10Baylor College of Medicine, Houston, TX
11Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, NY
12Duke University, Durham, NC
13National Heart, Lung, and Blood Institute and National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD
14University of Minnesota, Minneapolis, MN

9:45 AM

Franco Locatelli, MD1, Peter Lang, MD2*, Roland Meisel, MD3*, Donna Wall, MD4, Selim Corbacioglu, MD, PhD5, Amanda M Li, MD6, Josu de la Fuente, PhD FRCP7, Ami J. Shah, MD8, Ben Carpenter, MD9*, Janet L. Kwiatkowski, MD10, Markus Y Mapara, MD11, Robert I. Liem, MD12, Maria Domenica Cappellini, MD13, Mattia Algeri, MD14*, Antonis Kattamis, MD15, Sujit Sheth, MD16, Stephan A. Grupp, MD, PhD10, Hayley Lynne Merkeley17, Kevin H.M. Kuo, MD, MSc, FRCPC18, Joachim Rupprecht2*, Puja Kohli, MD, MMSc19*, Gang Xu19*, Leorah Ross, MD, PhD19*, Yael Bobruff, PhD19*, Bo Tong19*, William Hobbs, MD, PhD19 and Haydar Frangoul, MD20

1IRCCS, Ospedale Pediatrico Bambino Gesù Rome, Catholic University of the Sacred Heart, Rome, Italy
2University of Tübingen, Tübingen, Germany
3Division of Pediatric Stem Cell Therapy, Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich-Heine-University, Duesseldorf, Germany
4The Hospital for Sick Children/University of Toronto, Toronto, Canada
5University of Regensburg, Regensburg, Germany
6BC Children’s Hospital, University of British Columbia, Vancouver, BC, Canada
7Imperial College Healthcare Trust, St Mary's Hospital, London, United Kingdom
8Stanford University, Palo Alto, CA
9University College London Hospitals NHS Foundation Trust, London, United Kingdom
10Children’s Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
11Division of Hematology/Oncology, Columbia University, New York, NY
12Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL
13University of Milan, Milan, Italy
14IRCCS, Ospedale Pediatrico Bambino Gesù Rome, Magna Graecia University of Catanzaro, Catanzaro, Italy
15National and Kapodistrian University of Athens, Athens, Greece
16Joan and Sanford I Weill Medical College of Cornell University, New York, NY
17Department of Medicine, The University of British Columbia, Vancouver, Canada
18Division of Hematology, University of Toronto, Toronto, ON, Canada
19Vertex Pharmaceuticals Incorporated, Boston, MA
20Sarah Cannon Research Institute at the Children's Hospital at TriStar Centennial, Nashville, TN

10:00 AM

Ashish O. Gupta, MBBS, MPH1, Akshay Sharma, MBBS2, Haydar Frangoul, MD3, Jignesh Dalal, MD4*, Julie Kanter, MD5, Asif Alavi, MD6*, John DiPersio, MD, PhD7*, Mary Eapen, MBBS, MS8, Jennifer J. Jaroscak, MD9, Ernesto Ayala, MD10, Edward D. Ziga, MD, MPH11*, Stacey Rifkin-Zenenberg, DO12, Alex C. Minella, MD13, Guo Chen, PhD13*, Yinzhong Chen, PhD13*, Priya S. Chockalingam, PhD13*, Ling Lin, PhD13*, Marcelyne Joseney-Antoine13*, Leanne Ianniello, MPH13*, Beth Gardner, BSc, EMBA, PMP13*, Adam J. Hartigan, PhD13*, Giuseppe Ciaramella, PhD, BSc13*, Sunita Goyal, MD13*, Amy Simon, MD13*, Alexis Thompson, MD, MPH14 and Matthew M. Heeney, MD15

1Division of Pediatric Blood and Marrow Transplant and Cellular Therapies, University of Minnesota, Minneapolis, MN
2Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN
3Sarah Cannon Research Institute at the Children's Hospital at TriStar Centennial, Nashville, TN
4Division of Hematology and Bone Marrow Transplant, Rainbow Babies & Children’s Hospital, Cleveland, OH
5Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL
6Henry Ford Health System, Detroit, MI
7Division of Oncology, Washington University, St Louis, MO
8Department of Medicine, The Medical College of Wisconsin, Inc., Milwaukee, WI
9Medical University of South Carolina, Charleston, SC
10Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL
11Miller School of Medicine, Miami, FL
12Pediatric Hematology/Oncology Division, Hackensack University Medical Center, Hackensack, NJ
13Beam Therapeutics Inc., Cambridge, MA
14Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, PA
15Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, MA

10:15 AM

Jack M Heath1*, Justin G Tedeschi1*, Upasana Sunil Arvindam, PhD1*, Simran Padhye1*, Kanut Laoharawee, PhD1*, Allen C Ng1*, David P Waterman, PhD1*, Matthew S Roy, PhD1*, Seth C Alexander, PhD1*, Sarah Trusiak, PhD1*, Christopher Divsalar, PhD1*, Azhaar Alturkistani, PhD1*, Barrett J Nehilla, PhD1*, Mallik R Putta, PhD1*, Katya Kosheleva, PhD1*, Hetal K Patel, PhD1*, Rowshon Alam, PhD1*, Stefanie Urlinger, PhD2*, Jeremy S Duffield, MD, PhD1* and Jennifer L Gori, PhD1

1Prime Medicine, Inc., Cambridge, MA
2Cimeio Therapeutics AG, Basel, Switzerland

10:30 AM

Lorenzo Tozzi, PhD1*, Giulia Schiroli, PhD1*, Yaser Heshmati, PhD2, Yu Cao, PhD1*, Michael T. Monte, MS1*, Apiwat Wangweerawong, PhD1*, James B. Rottman, PhD, DVM1*, Rahul Palchaudhuri, PhD1*, Jean-Antoine Ribeil, MD, PhD3*, John Manis, MD4, Hari Pujar, PhD1*, William Querbes, PhD1*, Anne Bothmer, PhD1*, Cecilia Cotta-Ramusino, PhD1*, Z. Jane Wang, PhD1*, William E. Salomon, PhD1* and Michael C Holmes, PhD1*

1Tessera Therapeutics, Somerville, MA
2Tessera Therapeutics, Newton, MA
3Sickle Cell Disease Center of Excellence, Boston University Chobanian and Avedisian School of Medicine, Boston, MA
4Transfusion Medicine, Boston Children's Hospital, Boston, MA

10:45 AM

Selami Demirci, PhD1*, Nandini Mondal, PhD2*, Wayne Austin2*, Henna Butt, MD1,3, Evan London1*, Shruti Sathish1*, Kathy Zhang2*, Jeffrey Wong2*, Hugh Kromer2*, Alexander Harmon2*, Jeremy Decker2*, Anh Le1*, Khaled Essawi, PhD4*, Allen E Krouse5*, N Seth Linde5*, Aylin Bonifacino5*, Theresa Engels5*, Justin Golomb5*, So Gun Hong, DVM, PhD5, Naoya Uchida, MD, PhD1, Nicole Gaudelli, PhD2*, Adam J. Hartigan, PhD2*, Charlotte F McDonagh, PhD2*, S Haihua Chu, PhD2*, Robert E Donahue, DVM1* and John Tisdale, MD6

1Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD
2Beam Therapeutics Inc, Cambridge, MA
3Children's National Hospital, Washington, DC
4Department of Medical Laboratory Technology, College of Applied Medical Sciences, Jazan University, Gizan, Saudi Arabia
5Translational Stem Cell Biology Branch, NHLBI, NIH, Bethesda, MD
6National Institutes of Health, Bethesda, MD

*signifies non-member of ASH